Jeremy Grantham's RMD Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 18,923 shares of ResMed Inc. (RMD) worth $4.25 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in RMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2014, adding 84,343 shares. Largest reduction occurred in Q3 2014, reducing 40,600 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +18,923 | New Buy | 18,923 | $224.48 |
| Q1 2016 | -37,303 | Sold Out | 0 | $0.00 |
| Q4 2015 | -35,200 | Reduce 48.55% | 37,303 | $53.70 |
| Q3 2015 | -37,400 | Reduce 34.03% | 72,503 | $50.96 |
| Q2 2015 | -800 | Reduce 0.72% | 109,903 | $56.37 |
| Q1 2015 | -200 | Reduce 0.18% | 110,703 | $71.78 |
| Q4 2014 | -23,811 | Reduce 17.68% | 110,903 | $56.06 |
| Q3 2014 | -40,600 | Reduce 23.16% | 134,714 | $49.27 |
| Q2 2014 | +4,500 | Add 2.63% | 175,314 | $50.63 |
| Q1 2014 | +84,343 | Add 97.54% | 170,814 | $44.69 |
| Q4 2013 | -329 | Reduce 0.38% | 86,471 | $47.08 |
| Q3 2013 | +24,458 | Add 39.23% | 86,800 | $52.82 |
| Q2 2013 | +62,342 | Add 0.00% | 62,342 | $45.12 |
Jeremy Grantham's ResMed Investment FAQs
Jeremy Grantham first purchased ResMed Inc. (RMD) in Q2 2013, acquiring 62,342 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held ResMed Inc. (RMD) for 13 quarters since Q2 2013.
Jeremy Grantham's largest addition to ResMed Inc. (RMD) was in Q1 2014, adding 170,814 shares worth $7.63 M.
According to the latest 13F filing for Q1 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 18,923 shares of ResMed Inc. (RMD), valued at approximately $4.25 M.
As of the Q1 2026 filing, ResMed Inc. (RMD) represents approximately 0.01% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in ResMed Inc. (RMD) was 175,314 shares, as reported at the end of Q2 2014.